Evolent Health Inc
NYSE:EVH
Evolent Health Inc
Cash from Financing Activities
Evolent Health Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Evolent Health Inc
NYSE:EVH
|
Cash from Financing Activities
$281.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Financing Activities
-$16.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Financing Activities
$14m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Financing Activities
-$74.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Cash from Financing Activities
-$9.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Financing Activities
-$167.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is Evolent Health Inc's Cash from Financing Activities?
Cash from Financing Activities
281.3m
USD
Based on the financial report for Dec 31, 2023, Evolent Health Inc's Cash from Financing Activities amounts to 281.3m USD.
What is Evolent Health Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
1%
Over the last year, the Cash from Financing Activities growth was 114%.